Magenta Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Magenta Therapeutics (NASDAQ: MGTA) announced its presentation at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021, at 10:50 a.m. ET, including a Q&A session. The event will be hosted virtually, and a live webcast will be available on the company's website. Magenta is focused on developing novel therapies aimed at utilizing immune system reset through stem cell transplants for patients with blood cancers, genetic conditions, and autoimmune diseases. The webcast replay will be accessible for 90 days post-event.

Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune reset to more patients, today announced that the company is scheduled to present at the 39^th Annual J.P. Morgan Healthcare Conference, to be held virtually, on Thursday, January 14^th, 2021, at 10:50 a.m. ET, immediately followed by a Q&A session.

A live webcast of the presentation and Q&A session can be accessed on the Magenta Therapeutics website at https://investor.magentatx.com/events-and-presentations. The webcast replay will be available for 90 days following the event.

About Magenta Therapeutics

Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of immune system reset through stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant world to revolutionize immune reset for more patients.

Magenta is based in Cambridge, Mass. For more information, please visit www.magentatx.com.

Follow Magenta on Twitter: @magentatx.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210105005204/en/

FAQ

When is Magenta Therapeutics presenting at the J.P. Morgan Healthcare Conference?

Magenta Therapeutics is scheduled to present on January 14, 2021, at 10:50 a.m. ET.

How can I access the Magenta Therapeutics presentation?

The presentation can be accessed live via webcast on the Magenta Therapeutics website.

What is the focus of Magenta Therapeutics' research?

Magenta Therapeutics focuses on developing therapies to reset the immune system using stem cell transplants.

How long will the webcast replay of the presentation be available?

The webcast replay will be available for 90 days following the event.

What does Magenta Therapeutics aim to achieve with its medicines?

Magenta aims to bring the curative power of immune reset to patients with blood cancers, genetic diseases, and autoimmune diseases.